Compare IOVA & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | REAX |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 790.0M |
| IPO Year | N/A | N/A |
| Metric | IOVA | REAX |
|---|---|---|
| Price | $2.22 | $3.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $10.36 | $6.33 |
| AVG Volume (30 Days) | ★ 16.6M | 1.3M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $250,425,000.00 | ★ $1,813,907,000.00 |
| Revenue This Year | $60.94 | $56.57 |
| Revenue Next Year | $60.85 | $21.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 175.62 | 65.60 |
| 52 Week Low | $1.64 | $3.42 |
| 52 Week High | $9.30 | $5.65 |
| Indicator | IOVA | REAX |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 52.02 |
| Support Level | $2.13 | $3.73 |
| Resistance Level | $2.55 | $4.01 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 25.57 | 76.61 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.